Toyota|$17.91 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$25.08 (¥3,960)+0.00%▲ (in JPY terms)
SoftBank|$28.84 (¥4,554)-6.01%▼ (in JPY terms)
MUFG|$21.22 (¥3,351)-3.65%▼ (in JPY terms)
Keyence|$512.38 (¥80,910)-0.61%▼ (in JPY terms)
Nintendo|$54.97 (¥8,680)+1.63%▲ (in JPY terms)
NTT|$1.12 (¥177)+1.14%▲ (in JPY terms)
Takeda|$39.96 (¥6,310)+1.06%▲ (in JPY terms)
Tokyo Electron|$63.87 (¥10,085)-2.56%▼ (in JPY terms)
Recruit|$119.05 (¥18,800)+0.13%▲ (in JPY terms)
ITOCHU|$14.55 (¥2,298)-0.95%▼ (in JPY terms)
Honda|$11.42 (¥1,804)-0.19%▼ (in JPY terms)
Shin-Etsu|$37.17 (¥5,869)-1.63%▼ (in JPY terms)
Tokio Marine|$3.45 (¥544)-1.91%▼ (in JPY terms)
Fast Retailing|$477.23 (¥75,360)+2.04%▲ (in JPY terms)
Toyota|$17.91 (¥2,828)+1.25%▲ (in JPY terms)
Sony|$25.08 (¥3,960)+0.00%▲ (in JPY terms)
SoftBank|$28.84 (¥4,554)-6.01%▼ (in JPY terms)
MUFG|$21.22 (¥3,351)-3.65%▼ (in JPY terms)
Keyence|$512.38 (¥80,910)-0.61%▼ (in JPY terms)
Nintendo|$54.97 (¥8,680)+1.63%▲ (in JPY terms)
NTT|$1.12 (¥177)+1.14%▲ (in JPY terms)
Takeda|$39.96 (¥6,310)+1.06%▲ (in JPY terms)
Tokyo Electron|$63.87 (¥10,085)-2.56%▼ (in JPY terms)
Recruit|$119.05 (¥18,800)+0.13%▲ (in JPY terms)
ITOCHU|$14.55 (¥2,298)-0.95%▼ (in JPY terms)
Honda|$11.42 (¥1,804)-0.19%▼ (in JPY terms)
Shin-Etsu|$37.17 (¥5,869)-1.63%▼ (in JPY terms)
Tokio Marine|$3.45 (¥544)-1.91%▼ (in JPY terms)
Fast Retailing|$477.23 (¥75,360)+2.04%▲ (in JPY terms)

2026-06-25 Otsuka Holdings Co.,Ltd. “Centanafadine, a novel attention-deficit/hyperactivity disorder (ADHD) treatment with a new mechanism of action: Positive results from a Phase 3b trial in adult ADHD patients with concomitant anxiety disorders.”

by

2026-06-25 Otsuka Holdings Co.,Ltd. “Centanafadine, a novel attention-deficit/hyperactivity disorder (ADHD) treatment with a new mechanism of action: Positive results from a Phase 3b trial in adult ADHD patients with concomitant anxiety disorders.”

Tags: JP3188220002Otsuka Holdings Co.,Ltd.

コメントする

Contact